COVID-19 Testing Coverage Act of 2021  This bill requires private health insurance to cover, without cost sharing, testing to assess the T cell immune response of an individual to COVID-19. This test indicates a recent or prior infection with COVID-19.
To amend the Families First Coronavirus Response Act to require group 
   health plans and health insurance issuers to cover T cell immune 
        response testing without the imposition of cost sharing.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``COVID-19 Testing Coverage Act of 
2021''.

SEC. 2. REQUIRING GROUP HEALTH PLANS AND HEALTH INSURANCE ISSUERS TO 
              COVER T CELL IMMUNE RESPONSE TESTING WITHOUT THE 
              IMPOSITION OF COST SHARING.

    Section 6001(a) of the Families First Coronavirus Response Act (42 
U.S.C. 1320b-5 note) is amended--
            (1) in the matter preceding paragraph (1), by inserting 
        ``(or, in the case of tests described in paragraph (3), 
        beginning on or after the date of the enactment of such 
        paragraph)'' after ``the date of the enactment of this Act''; 
        and
            (2) by adding at the end the following new paragraph:
            ``(3) Tests furnished to assess the T cell immune response 
        of an individual to COVID-19.''.
                                 <all>
COVID–19 Testing Coverage Act of 2021
To amend the Families First Coronavirus Response Act to require group health plans and health insurance issuers to cover T cell immune response testing without the imposition of cost sharing.
COVID–19 Testing Coverage Act of 2021
Rep. Miller-Meeks, Mariannette